EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation

Ricardo Lage, María Cebro-Márquez iD, Marta E Vilar-Sánchez iD, Laila González-Melchor, Javier García-Seara, José Luis Martínez-Sande, Xesús Alberte Fernández-López, Alana Aragón-Herrera iD, María Amparo Martínez-Monzonís, José Ramón González-Juanatey iD, Moisés Rodríguez-Mañero, Isabel Moscoso iD

Cells · 16.02.2023 · 12 (4) · 638

DOI: 10.3390/cells12040638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 16.02.2023. Verfasst von Ricardo Lage und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Group, Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, 15782 Santiago de C…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, MicroRNAs, Catheter Ablation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xunta de Galicia, Centro Singular de Investigación de Galicia acreditación 2019–2022, European Union European Regional Development Fund (ERDF), and National Institute of Health “Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation is the most prevalent tachyarrhythmia in clinical practice, with very high cardiovascular morbidity and mortality with a high-cost impact in health systems. Currently, it is one of the main causes of stroke and subsequent heart failure and sudden death. miRNAs mediate in several processes involved in cardiovascular disease, including fibrosis and electrical and structural remodeling. Several studies suggest a key role of miRNAs in the course and maintenance of atrial fibrillation. In our study, we aimed to identify the differential expression of circulating miRNAs and their predictive value as biomarkers of recurrence in atrial fibrillation patients undergoing catheter pulmonary vein ablation. To this effect, 42 atrial fibrillation patients were recruited for catheter ablation. We measured the expression of 84 miRNAs in non-recurrent and recurrent groups (45.2%), both in plasma from peripheral and left atrium blood. Expression analysis showed that miRNA-451a is downregulated in recurrent patients. Receiver operating characteristic curve analysis showed that miR-451a in left atrium plasma could predict atrial fibrillation recurrence after pulmonary vein isolation. In addition, atrial fibrillation recurrence is positively associated with the increment of scar percentage. Our data suggest that miRNA-451a expression plays an important role in AF recurrence by controlling fibrosis and progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPulmonary VeinsMicroRNAsCatheter AblationHumansFibrosisCatheters

Stichwörter der Autor:innen

atrial fibrillationbiomarkermiR-451amicroRNAsrecurrencescar percentage

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Cardiology Group, Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
  • Department of Cardiology and Coronary Unit and Cellular and Molecular Cardiology Research Unit, Institute of Biomedical Research (IDIS-SERGAS), University Clinical Hospital, 15706 Santiago de Compostela, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.

ORCID-Profile: María Cebro-Márquez, Marta E Vilar-Sánchez, Alana Aragón-Herrera, José Ramón González-Juanatey, Isabel Moscoso

Förderung

  • Xunta de Galicia
  • Centro Singular de Investigación de Galicia acreditación 2019–2022
  • European Union European Regional Development Fund (ERDF), and National Institute of Health “Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III…

Zitieren

APA

Lage, R., Cebro-Márquez, M., Vilar-Sánchez, M. E., González-Melchor, L., García-Seara, J., Martínez-Sande, J. L., Fernández-López, X. A., Aragón-Herrera, A., Martínez-Monzonís, M. A., González-Juanatey, J. R., Rodríguez-Mañero, M., & Moscoso, I. (2023). Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation. Cells, 12(4), 638. https://doi.org/10.3390/cells12040638

Vancouver

Lage R, Cebro-Márquez M, Vilar-Sánchez ME, González-Melchor L, García-Seara J, Martínez-Sande JL, et al. Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation. Cells. 2023;12(4):638. doi:10.3390/cells12040638

BibTeX
@article{Lage2023,
  author = {Lage, Ricardo and Cebro-Márquez, María and Vilar-Sánchez, Marta E and González-Melchor, Laila and García-Seara, Javier and Martínez-Sande, José Luis and Fernández-López, Xesús Alberte and Aragón-Herrera, Alana and Martínez-Monzonís, María Amparo and González-Juanatey, José Ramón and Rodríguez-Mañero, Moisés and Moscoso, Isabel},
  title = {Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {4},
  pages = {638},
  doi = {10.3390/cells12040638}
}
Kostenlos starten →